药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Tetracosactide
Clinafloxacin
The risk or severity of hypoglycemia can be increased when Clinafloxacin is combined with Linagliptin.
Tetracosactide
Cibenzoline
The risk or severity of hypoglycemia can be increased when Cibenzoline is combined with Linagliptin.
Tetracosactide
Alaproclate
The risk or severity of hypoglycemia can be increased when Alaproclate is combined with Linagliptin.
Tetracosactide
Ritanserin
The risk or severity of hypoglycemia can be increased when Ritanserin is combined with Linagliptin.
Tetracosactide
Mesterolone
Mesterolone may increase the hypoglycemic activities of Linagliptin.
Tetracosactide
Nandrolone
Nandrolone may increase the hypoglycemic activities of Linagliptin.
Tetracosactide
GLPG-0492
GLPG-0492 may increase the hypoglycemic activities of Linagliptin.
Tetracosactide
Nandrolone decanoate
Nandrolone decanoate may increase the hypoglycemic activities of Linagliptin.
Tetracosactide
Stanozolol
Stanozolol may increase the hypoglycemic activities of Linagliptin.
Tetracosactide
Fosamprenavir
The therapeutic efficacy of Linagliptin can be decreased when used in combination with Fosamprenavir.
Tetracosactide
Teprotumumab
The therapeutic efficacy of Linagliptin can be decreased when used in combination with Teprotumumab.
Tetracosactide
Dienogest
The therapeutic efficacy of Linagliptin can be decreased when used in combination with Dienogest.
Tetracosactide
Articaine
The therapeutic efficacy of Linagliptin can be decreased when used in combination with Articaine.
Tetracosactide
Triptorelin
The therapeutic efficacy of Linagliptin can be decreased when used in combination with Triptorelin.
Tetracosactide
Lanreotide
The therapeutic efficacy of Linagliptin can be decreased when used in combination with Lanreotide.
Tetracosactide
Hydroxyprogesterone caproate
The therapeutic efficacy of Linagliptin can be decreased when used in combination with Hydroxyprogesterone caproate.
Tetracosactide
Histrelin
The therapeutic efficacy of Linagliptin can be decreased when used in combination with Histrelin.
Tetracosactide
Buserelin
The therapeutic efficacy of Linagliptin can be decreased when used in combination with Buserelin.
Tetracosactide
Pasireotide
The therapeutic efficacy of Linagliptin can be decreased when used in combination with Pasireotide.
Tetracosactide
Asenapine
The therapeutic efficacy of Linagliptin can be decreased when used in combination with Asenapine.